Resources

In his fifth year with Team Novo Nordisk, Stephen Clancy is slated to race his second consecutive Tour of Utah. At last year’s race, Stephen said it was an unforgettable experience racing at arguably the toughest race in the United States.

Dr. Davidson discusses new diabetes drugs and their impact on patient health, including DKA; new combination drugs; and the expensive side effects of sulfonylureas.

In this Exclusive Interview, Dr. Davidson discusses his thoughts on new drugs and their impact on patient health, such as DKA.

In this week's Homerun Slides, the phenotypic presentation of the beta-cell.

Glucose phosphorylation and glucose transport are tightly coupled phenomena. Isoenzymes of HK (HK-I to HK-IV) catalyze the first committed intracellular step of glucose metabolism, the conversion of glucose to G-6-P. HK-I, HK-II, HK-III are single-chain peptides that have a number of properties in common, including a very high affinity for glucose and product inhibition by G-6-P.

Study authors sought to characterize the tolerance test, and HbA1c—in a population of patients with coronary artery disease (CAD).

Apart from Sotagliflozin’s use in the treatment of people with type 2, SGLT-1 and SGLT-2 inhibitors effects on type 1 currently being explored.

Study aims to distinguish different antidiabetic drugs and their effect on osteoporosis in people with diabetes.

People with type 1 diabetes receiving once-daily injection of glucagon-blocking drug, REMD-477 can reduce their insulin use considerably and improve blood glucose levels without altering hypoglycemia.

Older adults taking five or more drugs are likely to exhibit negative side effects.